StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
27
Publishing Date
2023 - 11 - 28
1
2023 - 10 - 23
1
2022 - 08 - 24
1
2022 - 08 - 08
1
2022 - 04 - 08
1
2021 - 11 - 29
1
2021 - 09 - 17
1
2021 - 07 - 27
1
2021 - 07 - 22
1
2021 - 07 - 16
1
2021 - 07 - 12
1
2021 - 07 - 09
1
2021 - 07 - 01
1
2021 - 06 - 16
1
2021 - 06 - 11
1
2021 - 06 - 09
1
2021 - 05 - 28
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 11
1
2021 - 05 - 05
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 07
1
Sector
Health services
1
Health technology
27
Tags
Acquisition
2
Alliances
2
Application
3
Approval
23
Asco
2
Authorized
1
Ayvakit
9
Ayvakyt
5
Benefits
1
Biocanada
1
Biomarker
1
Biotechnology
1
Blu-222
2
Blu-945
1
Blue
4
Business
2
Cancer
27
Cell
2
Ceo
1
Ces
2
China
1
Chmp
3
Clinical hold
1
Collaboration
2
Conference
4
Day
3
Disease
2
Drug
4
Earnings
10
Events
3
Fda
7
Fda approval
2
Financial
8
Financial results
8
First
2
Gastrointestinal
2
Genetown
19
Grant
6
Granted
5
Grants
14
Health
2
Label
2
Lung cancer
2
Market
2
Meeting
6
N/a
82
Nasdaq
14
People
5
Pharma
2
Pipeline
2
Positive
5
Report
10
Research
6
Results
31
Study
2
Therapeutics
6
Therapy
7
Treatment
12
Trial
6
Year
4
Entities
Abbvie inc.
10
Adc therapeutics sa
13
Agios pharmaceuticals, inc.
10
Alnylam pharmaceuticals, inc.
10
Amgen inc.
10
Anixa biosciences, inc.
1
Astrazeneca plc
1
Aveo pharmaceuticals, inc.
18
Beigene, ltd.
10
Blueprint medicines corporation
27
Bristol-myers squibb company
18
Clovis oncology, inc.
18
Eli lilly and company
19
Epizyme, inc.
18
Exelixis, inc.
10
Glycomimetics, inc.
1
Guardant health, inc.
1
Illumina, inc.
10
Immunogen, inc.
1
Incyte corporation
18
Johnson & johnson
1
Karyopharm therapeutics inc.
18
Pfizer, inc.
10
Regeneron pharmaceuticals, inc.
18
Rigel pharmaceuticals, inc.
10
Sanofi
19
Verastem, inc.
10
Y-mabs therapeutics, inc.
18
Symbols
A
27
ABBV
53
ABT
48
ALPMF
49
ALPMY
49
AMGN
91
ANIX
49
ARAY
26
AVEO
24
AZN
144
AZNCF
74
BCTX
50
BDX
26
BGNE
58
BIOC
31
BMY
107
BPMC
27
CLVS
33
CSTL
28
EXAS
56
EXEL
43
FNCTF
138
GH
53
GILD
59
GLAXF
46
GNPX
26
GSK
54
GTHX
27
HOLX
32
HOTH
29
IBRX
29
ILMN
68
IMGN
25
IMMP
34
INCY
57
JAGX
36
JNJ
138
KPTI
27
LLY
139
LTRN
24
MRK
75
MRTX
32
MYGN
50
NTRA
38
NVCR
30
NVS
106
NVSEF
91
NVTA
25
ONCY
41
PDSB
34
PFE
66
QGEN
31
REGN
42
SGEN
55
SNY
215
SNYNF
165
TAK
34
TMO
51
VCYT
45
VSTM
25
Exchanges
Nasdaq
27
Nyse
19
Crawled Date
2023 - 11 - 28
1
2023 - 10 - 23
1
2022 - 08 - 24
1
2022 - 08 - 08
1
2022 - 04 - 08
1
2021 - 11 - 29
1
2021 - 09 - 17
1
2021 - 07 - 27
1
2021 - 07 - 22
1
2021 - 07 - 16
1
2021 - 07 - 13
1
2021 - 07 - 09
1
2021 - 07 - 01
1
2021 - 06 - 16
1
2021 - 06 - 11
1
2021 - 06 - 09
1
2021 - 05 - 28
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 11
1
2021 - 05 - 05
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 07
1
Crawled Time
00:01
1
08:00
1
11:00
1
11:36
1
12:00
2
12:30
1
13:13
1
13:47
1
13:50
1
14:58
1
16:00
1
17:37
1
18:04
1
18:17
1
18:26
1
18:31
2
18:33
1
18:40
1
18:42
1
19:00
1
19:11
1
19:32
1
19:52
1
20:59
1
22:00
1
Source
www.biospace.com
4
www.fda.gov
19
www.globenewswire.com
1
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
symbols :
Bpmc
save search
Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on its Immune/Molecular Biomarker Types: PD-L1, EGFR, KRAS, ALK, BRAF, MET, ROS-1, HER2, RET fusion, and NTRK1/2/3 Gene fusion | DelveInsight
Published:
2023-11-28
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.27%
|
O:
-0.04%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
26.85%
|
O:
-0.06%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.13%
|
O:
-0.15%
H:
0.07%
C:
-0.66%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
28.59%
|
O:
0.5%
H:
1.86%
C:
-0.33%
lung
biomarker
cancer
cell
market
Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board
Published:
2023-10-23
(Crawled : 12:30)
- prnewswire.com
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
120.78%
|
O:
-0.49%
H:
0.0%
C:
-11.51%
GLYC
|
$1.93
-10.65%
-11.92%
1.2M
|
Health Technology
|
80.95%
|
O:
0.0%
H:
0.79%
C:
-7.14%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
90.21%
|
O:
-1.06%
H:
1.36%
C:
-3.46%
ANIX
|
$3.12
0.65%
0.64%
33K
|
Health Technology
|
-0.64%
|
O:
3.19%
H:
1.55%
C:
0.31%
business
cancer
medical
CANCER Publishes Study Demonstrating Substantial Disease Burden for Patients with Systemic Mastocytosis
Published:
2022-08-24
(Crawled : 16:00)
- biospace.com/
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
22.65%
|
O:
0.17%
H:
6.36%
C:
4.29%
disease
cancer
study
Guardant Health and Blueprint Medicines present real-world data identifying EGFR C797X mutation as most common resistance mechanism to osimertinib therapy at IASLC 2022 World Conference on Lung Cancer
Published:
2022-08-08
(Crawled : 11:00)
- biospace.com/
GH
M
|
$16.08
-3.54%
-3.67%
1.9M
|
Health Services
|
-69.03%
|
O:
1.28%
H:
6.88%
C:
1.68%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
29.02%
|
O:
0.88%
H:
3.62%
C:
3.42%
conference
health
therapy
cancer
Blueprint Medicines Announces BLU-945 Proof-of-Concept Data Supporting Initiation of Comprehensive Combination Development Strategy in EGFR-mutant Non-Small Cell Lung Cancer
Published:
2022-04-08
(Crawled : 19:00)
- biospace.com/
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
28.61%
|
O:
0.94%
H:
3.74%
C:
0.86%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-3.87%
|
O:
-0.55%
H:
1.53%
C:
0.74%
blu-945
cancer
Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Published:
2021-11-29
(Crawled : 12:00)
- prnewswire.com
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
-15.26%
|
O:
-1.25%
H:
0.22%
C:
-4.07%
acquisition
lung cancer
therapy
cancer
therapeutics
Roche receives positive CHMP opinion for Gavreto® (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer
Published:
2021-09-17
(Crawled : 12:00)
- globenewswire.com
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
-14.61%
|
O:
-0.45%
H:
0.0%
C:
0.0%
treatment
lung cancer
positive
cancer
chmp
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-27
(Crawled : 14:58)
- fda.gov
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
208.69%
|
O:
0.21%
H:
0.14%
C:
-0.05%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-28.65%
|
O:
-0.64%
H:
0.68%
C:
0.34%
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
-77.38%
|
O:
-0.05%
H:
1.0%
C:
-2.76%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-53.83%
|
O:
-0.67%
H:
2.09%
C:
-0.18%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.85%
|
O:
-0.54%
H:
0.65%
C:
0.49%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
55.97%
|
O:
-1.6%
H:
2.25%
C:
2.2%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-85.03%
|
O:
-0.47%
H:
1.53%
C:
-0.35%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-31.68%
|
O:
-0.41%
H:
0.14%
C:
-0.84%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-77.83%
|
O:
2.34%
H:
0.37%
C:
-1.69%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.19%
|
O:
-0.21%
H:
4.42%
C:
2.74%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
7.31%
|
O:
-0.12%
H:
0.58%
C:
-0.16%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
191.17%
|
O:
-1.17%
H:
2.55%
C:
0.59%
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-22
(Crawled : 11:36)
- fda.gov
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
216.39%
|
O:
-0.0%
H:
1.02%
C:
0.51%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-28.08%
|
O:
-0.03%
H:
1.28%
C:
1.22%
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
-78.85%
|
O:
0.18%
H:
0.31%
C:
-2.26%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-56.89%
|
O:
-1.57%
H:
3.71%
C:
0.43%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.63%
|
O:
0.45%
H:
0.12%
C:
-0.6%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
54.39%
|
O:
-0.36%
H:
1.56%
C:
0.9%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-86.32%
|
O:
-0.53%
H:
0.38%
C:
-3.01%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-33.26%
|
O:
-0.39%
H:
0.11%
C:
-0.27%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-80.03%
|
O:
-1.49%
H:
2.0%
C:
-2.34%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.35%
|
O:
0.0%
H:
0.58%
C:
-3.46%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
2.7%
|
O:
-0.84%
H:
1.72%
C:
0.61%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
176.66%
|
O:
2.21%
H:
0.0%
C:
-4.87%
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-16
(Crawled : 19:11)
- fda.gov
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-12
(Crawled : 00:01)
- fda.gov
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
216.13%
|
O:
-0.98%
H:
1.2%
C:
0.36%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-28.08%
|
O:
-0.15%
H:
1.19%
C:
0.66%
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
-80.54%
|
O:
-0.41%
H:
2.22%
C:
-1.07%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-54.13%
|
O:
0.03%
H:
1.08%
C:
-0.36%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.94%
|
O:
1.84%
H:
0.27%
C:
-0.38%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
55.27%
|
O:
-0.08%
H:
1.11%
C:
-1.02%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-87.28%
|
O:
0.1%
H:
1.48%
C:
-3.38%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-35.62%
|
O:
0.0%
H:
0.49%
C:
-1.05%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-80.98%
|
O:
-0.26%
H:
1.09%
C:
-0.52%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.41%
|
O:
5.35%
H:
0.7%
C:
-7.18%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
2.26%
|
O:
-0.21%
H:
0.05%
C:
-2.51%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
144.62%
|
O:
1.47%
H:
0.0%
C:
-5.79%
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-09
(Crawled : 18:17)
- fda.gov
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-01
(Crawled : 13:13)
- fda.gov
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
227.1%
|
O:
-0.0%
H:
0.87%
C:
0.71%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-27.72%
|
O:
-0.6%
H:
0.48%
C:
0.21%
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
-80.45%
|
O:
-0.45%
H:
2.35%
C:
1.86%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-55.3%
|
O:
0.24%
H:
3.9%
C:
3.69%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.58%
|
O:
-0.27%
H:
0.36%
C:
0.08%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
61.35%
|
O:
-0.35%
H:
3.65%
C:
3.24%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-87.6%
|
O:
0.0%
H:
3.0%
C:
3.0%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-37.22%
|
O:
-0.05%
H:
0.49%
C:
-0.08%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-82.31%
|
O:
0.84%
H:
1.67%
C:
0.95%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.52%
|
O:
0.0%
H:
1.9%
C:
0.0%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
-0.05%
|
O:
0.0%
H:
0.67%
C:
-0.34%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
127.54%
|
O:
1.21%
H:
0.0%
C:
-5.55%
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-06-16
(Crawled : 19:52)
- fda.gov
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
240.08%
|
O:
-0.22%
H:
1.28%
C:
0.88%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-27.82%
|
O:
0.16%
H:
0.21%
C:
-0.39%
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
-79.31%
|
O:
0.0%
H:
1.87%
C:
-0.04%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-57.77%
|
O:
0.0%
H:
5.48%
C:
5.2%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.81%
|
O:
-0.98%
H:
0.77%
C:
0.65%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
72.12%
|
O:
0.08%
H:
2.77%
C:
2.29%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-87.24%
|
O:
-0.8%
H:
6.08%
C:
5.53%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-36.45%
|
O:
-0.29%
H:
0.84%
C:
0.3%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.35%
|
O:
-0.45%
H:
1.02%
C:
0.23%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.54%
|
O:
1.35%
H:
5.34%
C:
1.67%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
2.75%
|
O:
-0.81%
H:
3.66%
C:
-1.58%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
119.55%
|
O:
-0.29%
H:
1.76%
C:
-2.5%
cancer
approval
FDA approves pralsetinib for RET-altered thyroid cancers
Published:
2021-06-11
(Crawled : 13:47)
- fda.gov
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
4.52%
|
O:
1.41%
H:
2.24%
C:
1.88%
cancer
fda
approval
fda approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-06-09
(Crawled : 19:32)
- fda.gov
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
232.2%
|
O:
0.43%
H:
3.91%
C:
2.89%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-26.15%
|
O:
0.23%
H:
3.28%
C:
2.81%
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
-78.0%
|
O:
1.34%
H:
2.51%
C:
1.32%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-58.47%
|
O:
-0.14%
H:
5.67%
C:
3.3%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.77%
|
O:
1.21%
H:
1.07%
C:
0.67%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
72.69%
|
O:
-0.11%
H:
2.3%
C:
2.07%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-87.23%
|
O:
0.9%
H:
4.35%
C:
4.35%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-38.72%
|
O:
0.21%
H:
1.47%
C:
1.33%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-82.64%
|
O:
0.12%
H:
1.53%
C:
0.0%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.64%
|
O:
-3.25%
H:
2.87%
C:
-2.21%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
5.96%
|
O:
0.04%
H:
1.73%
C:
1.34%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
106.26%
|
O:
-0.28%
H:
1.38%
C:
-0.55%
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-28
(Crawled : 18:31)
- fda.gov
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
Email alert
Add to watchlist
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
VSTM
|
$9.86
-3.62%
-3.75%
150K
|
Health Technology
|
Email alert
Add to watchlist
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
Email alert
Add to watchlist
ILMN
|
$117.43
0.63%
0.63%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
Email alert
Add to watchlist
AGIO
|
$29.52
0.31%
0.3%
750K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-21
(Crawled : 18:33)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-36.64%
|
O:
0.22%
H:
0.97%
C:
-0.65%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
276.27%
|
O:
0.24%
H:
0.96%
C:
-0.06%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-27.91%
|
O:
0.36%
H:
1.01%
C:
-0.28%
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
-76.76%
|
O:
2.54%
H:
0.48%
C:
-0.29%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
41.03%
|
O:
0.35%
H:
0.65%
C:
-1.19%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-58.07%
|
O:
0.58%
H:
1.24%
C:
-1.66%
VSTM
|
$9.86
-3.62%
-3.75%
150K
|
Health Technology
|
220.69%
|
O:
0.63%
H:
2.49%
C:
-0.62%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.78%
|
O:
-0.43%
H:
0.2%
C:
0.02%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-71.47%
|
O:
0.82%
H:
1.08%
C:
-1.62%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
75.6%
|
O:
0.18%
H:
0.46%
C:
-1.44%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-86.57%
|
O:
0.31%
H:
1.15%
C:
-1.46%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-36.75%
|
O:
0.57%
H:
0.6%
C:
-1.46%
ILMN
|
$117.43
0.63%
0.63%
1.4M
|
Health Technology
|
-70.16%
|
O:
0.33%
H:
2.2%
C:
0.21%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
-5.36%
|
O:
0.08%
H:
1.64%
C:
0.45%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.08%
|
O:
1.04%
H:
0.0%
C:
-2.62%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.37%
|
O:
0.95%
H:
1.31%
C:
-2.81%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
-7.87%
|
O:
1.12%
H:
0.84%
C:
-0.08%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-61.05%
|
O:
0.1%
H:
1.6%
C:
0.88%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
115.45%
|
O:
1.19%
H:
1.71%
C:
-0.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
5.16%
|
O:
0.71%
H:
0.14%
C:
-1.06%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
3.61%
|
O:
0.38%
H:
1.01%
C:
-0.41%
AGIO
|
$29.52
0.31%
0.3%
750K
|
Health Technology
|
-48.64%
|
O:
0.86%
H:
1.27%
C:
-0.24%
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-20
(Crawled : 18:26)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-36.64%
|
O:
0.22%
H:
0.97%
C:
-0.65%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
276.27%
|
O:
0.24%
H:
0.96%
C:
-0.06%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-27.91%
|
O:
0.36%
H:
1.01%
C:
-0.28%
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
-76.76%
|
O:
2.54%
H:
0.48%
C:
-0.29%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
41.03%
|
O:
0.35%
H:
0.65%
C:
-1.19%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-58.07%
|
O:
0.58%
H:
1.24%
C:
-1.66%
VSTM
|
$9.86
-3.62%
-3.75%
150K
|
Health Technology
|
220.69%
|
O:
0.63%
H:
2.49%
C:
-0.62%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.78%
|
O:
-0.43%
H:
0.2%
C:
0.02%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-71.47%
|
O:
0.82%
H:
1.08%
C:
-1.62%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
75.6%
|
O:
0.18%
H:
0.46%
C:
-1.44%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-86.57%
|
O:
0.31%
H:
1.15%
C:
-1.46%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-36.75%
|
O:
0.57%
H:
0.6%
C:
-1.46%
ILMN
|
$117.43
0.63%
0.63%
1.4M
|
Health Technology
|
-70.16%
|
O:
0.33%
H:
2.2%
C:
0.21%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
-5.36%
|
O:
0.08%
H:
1.64%
C:
0.45%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.08%
|
O:
1.04%
H:
0.0%
C:
-2.62%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.37%
|
O:
0.95%
H:
1.31%
C:
-2.81%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
-7.87%
|
O:
1.12%
H:
0.84%
C:
-0.08%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-61.05%
|
O:
0.1%
H:
1.6%
C:
0.88%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
115.45%
|
O:
1.19%
H:
1.71%
C:
-0.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
5.16%
|
O:
0.71%
H:
0.14%
C:
-1.06%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
3.61%
|
O:
0.38%
H:
1.01%
C:
-0.41%
AGIO
|
$29.52
0.31%
0.3%
750K
|
Health Technology
|
-48.64%
|
O:
0.86%
H:
1.27%
C:
-0.24%
cancer
approval
Genentech to Present Data From One of the Most Comprehensive Oncology Portfolios at the 2021 ASCO Annual Meeting Showcasing Advancements for People Living With Cancer
Published:
2021-05-11
(Crawled : 08:00)
- biospace.com/
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
-4.66%
|
O:
-3.59%
H:
8.16%
C:
5.44%
cancer
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.